Member Info for Scinv_temp

So these patents are more about proving that they are not infringing someone else's IP, rather than preventing 3rd parties from doing something sufficiently similar to be the same in practice.

It isn't about whether it is published or not. It is about the scope. SNG need to have a patent in order to sell anything, this is what they will be selling (and perhaps their current stock, but that's not where any value comes from). These are the FTO patents. If carefully crafted they do get published but have zero value in protecting from copycats, even if specific claims that seem protective are actually published. Literally anyone can make something indisnguishly similar and sell it in the same market and SNG will do nothing about it, because if they do try to enforce they will end up losing their own patent. Ifnb, including nebulised for respiratory diseases/conditions has been around for decades. In fact has been failing to make a breakthrough for ages. If somehow someone finds a way to make it useful, others will join in no time and SNG will not be able to do anything about that, except try to sell their own version of it.

CSO will present the data on the pre print at some point in the future. That previously she had the role of ceo, cso and cmo was travesty.

🤣🤣🤣🤣

CSO, CMO different roles on the same level.

Corporate updates are given by CEOs and CFOs, clinical by CMOs. So the presenting team is consistent with the announced update type. However, in addition to "ahead of future data" hint on the linked in page, I would expect the CSO to be there when significantly positive data on her babies are announced.

My guess CVLP cohort 4 update and perhaps change of strategy to ADCs on the corporate side (that would actually be a good thing, if they can fund it).

C-level changes need to be on an RNS. Tomorrow morning should reveal whether there are any changes or data release.

Reminder

Scinv_temp

Posted in: SCLP

Posts: 1,800

Price: 9.775

No Opinion

RE: How confident are we that results will arrive in July?18 Jun 2025 12:50

Best one you can hope for is 1st patient dosed in cohort 4

"ahead of future"

"ahead"

It's great to have people sharply focused on what's important. To the moon🚀🚀

If the data is so good, where is it?

Tik tok...

*Misled

I happen to know HGF well. Yes they are top. But not every patent is about excluding others. Most of them are about FTO. There is a difference and HGF understand that very well, and so does SNG management. It is the investors that get misleaded.

Nana says Burble is not a vet salesman. OK.

Might as well be though, cause he understands nothing apart from the most superficial stuff.

Those patents are commercially useless. Hopefully none of you considers buying from the new facility.

..or your "great prediction" if you like, in any case it is a very clear recommendation and prediction so hopefully you will continue to own it, just like you have so far (to your credit, you may be the only one here that has). I just hope you are not trying to get other people to buy so that you can exit :)

Matt, a reasonable comment other than it ignores the fact that this 11fold to 41fold that you suggest, is also your fault to expect.

You are right Burble. Care to comment about the graph that shows scib1 is useless but iscib1+ is the bees knees, as a "scientist"?

All my main points I have tried to discuss them in a very civil and reasonable manner in the past, but you never showed up. But now that you are here, can you discuss?

Or maybe it's because instead of the company releasing data, they release "fake confidential" interviews. What is there to say?